{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T04:08:44Z","timestamp":1788754124584,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11954-8","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T13:42:18Z","timestamp":1762782138000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Healthcare costs of invasive meningococcal disease: a nationwide population-based study using an innovative clustering method to identify sequelae"],"prefix":"10.1186","volume":"25","author":[{"given":"Xavier","family":"Duval","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Collin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexiane","family":"Baloche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Fanchon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Nora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Hoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"11954_CR1","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.jadohealth.2016.03.041","volume":"59","author":"F Martin\u00f3n-Torres","year":"2016","unstructured":"Martin\u00f3n-Torres F. Deciphering the burden of meningococcal disease: conventional and Under-recognized elements. J Adolesc Health. 2016;59:S12\u201320.","journal-title":"J Adolesc Health"},{"key":"11954_CR2","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1080\/21645515.2020.1849518","volume":"17","author":"MK Taha","year":"2021","unstructured":"Taha MK, Weil-Olivier C, Bou\u00e9e S, Emery C, Nachbaur G, Pribil C, et al. Risk factors for invasive meningococcal disease: a retrospective analysis of the French National public health insurance database. Hum Vaccines Immunotherapeutics. 2021;17:1858\u201366.","journal-title":"Hum Vaccines Immunotherapeutics"},{"key":"11954_CR3","doi-asserted-by":"crossref","first-page":"2021764","DOI":"10.1080\/21645515.2021.2021764","volume":"18","author":"C Weil-Olivier","year":"2022","unstructured":"Weil-Olivier C, Taha MK, Bou\u00e9e S, Emery C, Loncle-Provot V, Nachbaur G, et al. Care pathways in invasive meningococcal disease: a retrospective analysis of the French National public health insurance database. Hum Vaccines Immunotherapeutics. 2022;18:2021764.","journal-title":"Hum Vaccines Immunotherapeutics"},{"key":"11954_CR4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/INF.0000000000002251","volume":"38","author":"E Rampakakis","year":"2019","unstructured":"Rampakakis E, Vaillancourt J, Mursleen S, Sampalis JS. Healthcare resource utilization and cost of invasive meningococcal disease in Ontario, Canada. Pediatr Infect Dis J. 2019;38:253\u20137.","journal-title":"Pediatr Infect Dis J"},{"key":"11954_CR5","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s40121-021-00468-w","volume":"10","author":"C Weil-Olivier","year":"2021","unstructured":"Weil-Olivier C, Taha MK, Emery C, Bou\u00e9e S, Beck E, Aris E, et al. Healthcare resource consumption and cost of invasive meningococcal disease in france: A study of the National health insurance database. Infect Dis Ther. 2021;10:1607\u201323.","journal-title":"Infect Dis Ther"},{"key":"11954_CR6","doi-asserted-by":"crossref","first-page":"e0267786","DOI":"10.1371\/journal.pone.0267786","volume":"17","author":"L Huang","year":"2022","unstructured":"Huang L, Fievez S, Goguillot M, Mari\u00e9 L, B\u00e9nard S, Elka\u00efm A, et al. A database study of clinical and economic burden of invasive meningococcal disease in France. PLoS ONE. 2022;17:e0267786.","journal-title":"PLoS ONE"},{"key":"11954_CR7","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1186\/s12889-022-13342-2","volume":"22","author":"J Shen","year":"2022","unstructured":"Shen J, Begum N, Ruiz-Garcia Y, Martinon-Torres F, Bekkat-Berkani R, Meszaros K. Range of invasive meningococcal disease sequelae and health economic application - a systematic and clinical review. BMC Public Health. 2022;22:1078.","journal-title":"BMC Public Health"},{"key":"11954_CR8","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s40273-018-0679-5","volume":"36","author":"B Wang","year":"2018","unstructured":"Wang B, Santoreneos R, Afzali H, Giles L, Marshall H. Costs of invasive meningococcal disease: A global systematic review. PharmacoEconomics. 2018;36:1201\u201322.","journal-title":"PharmacoEconomics"},{"key":"11954_CR9","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/jpc.15350","volume":"57","author":"L Deng","year":"2021","unstructured":"Deng L, Barton B, Lorenzo J, Rashid H, Dastouri F, Booy R. Longer term outcomes following serogroup B invasive meningococcal disease. J Paediatr Child Health. 2021;57:894\u2013902.","journal-title":"J Paediatr Child Health"},{"key":"11954_CR10","doi-asserted-by":"crossref","first-page":"e0228020","DOI":"10.1371\/journal.pone.0228020","volume":"15","author":"L Huang","year":"2020","unstructured":"Huang L, Heuer OD, Jan\u00dfen S, H\u00e4ckl D, Schmedt N. Clinical and economic burden of invasive meningococcal disease: evidence from a large German claims database. PLoS ONE. 2020;15:e0228020.","journal-title":"PLoS ONE"},{"key":"11954_CR11","doi-asserted-by":"crossref","first-page":"2103319","DOI":"10.1080\/21645515.2022.2103319","volume":"18","author":"E Chacon-Cruz","year":"2022","unstructured":"Chacon-Cruz E, Lopatynsky-Reyes EZ, Huerta-Garcia G, Cervantes-Apolinar MY, Guzman-Holst A, Van Oorschot D. Economic burden of meningococcal disease in children and adolescents in Tijuana, Mexico. Hum Vaccin Immunother. 2022;18:2103319.","journal-title":"Hum Vaccin Immunother"},{"key":"11954_CR12","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s10198-021-01304-1","volume":"22","author":"A Tanguy-Melac","year":"2021","unstructured":"Tanguy-Melac A, Verboux D, Pestel L, Fagot-Campagna A, Tuppin P, Gastaldi-M\u00e9nager C. Evolution of health care utilization and expenditure during the year before death in 2015 among people with cancer: French SNDS-based cohort study. Eur J Health Econ. 2021;22:1039\u201352.","journal-title":"Eur J Health Econ"},{"key":"11954_CR13","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1532-5415.2010.02816.x","volume":"58","author":"AA Bohl","year":"2010","unstructured":"Bohl AA, Fishman PA, Ciol MA, Williams B, Logerfo J, Phelan EA. A longitudinal analysis of total 3-year healthcare costs for older adults who experience a fall requiring medical care. J Am Geriatr Soc. 2010;58:853\u201360.","journal-title":"J Am Geriatr Soc"},{"key":"11954_CR14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1186\/s12889-022-12933-3","volume":"22","author":"S Guedes","year":"2022","unstructured":"Guedes S, Bricout H, Langevin E, Tong S, Bertrand-Gerentes I. Epidemiology of invasive meningococcal disease and sequelae in the united Kingdom during the period 2008 to 2017 - a secondary database analysis. BMC Public Health. 2022;22:521.","journal-title":"BMC Public Health"},{"key":"11954_CR15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.therap.2018.09.072","volume":"74","author":"LM Scailteux","year":"2019","unstructured":"Scailteux LM, Droitcourt C, Balusson F, Nowak E, Kerbrat S, Dupuy A, et al. French administrative health care database (SNDS): the value of its enrichment. Therapie. 2019;74:215\u201323.","journal-title":"Therapie"},{"key":"11954_CR16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12942-024-00366-7","volume":"23","author":"M Bonal","year":"2024","unstructured":"Bonal M, Padilla C, Chevillard G, Lucas-Gabrielli V. A French classification to describe medical deserts: a multi-professional approach based on the first contact with the healthcare system. Int J Health Geogr. 2024;23:5.","journal-title":"Int J Health Geogr"},{"key":"11954_CR17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jad.2012.10.024","volume":"147","author":"K Kleine-Budde","year":"2013","unstructured":"Kleine-Budde K, M\u00fcller R, Kawohl W, Bramesfeld A, Moock J, R\u00f6ssler W. The cost of depression - a cost analysis from a large database. J Affect Disord. 2013;147:137\u201343.","journal-title":"J Affect Disord"},{"key":"11954_CR18","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.3390\/ijerph15091844","volume":"15","author":"S Moon","year":"2018","unstructured":"Moon S, Choi M. The effect of usual source of care on the association of annual healthcare expenditure with patients\u2019 age and chronic disease duration. Int J Environ Res Public Health. 2018;15:1844.","journal-title":"Int J Environ Res Public Health"},{"key":"11954_CR19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jinf.2020.05.079","volume":"81","author":"SR Parikh","year":"2020","unstructured":"Parikh SR, Campbell H, Bettinger JA, Harrison LH, Marshall HS, Martinon-Torres F, et al. The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination. J Infect. 2020;81:483\u201398.","journal-title":"J Infect"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11954-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11954-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11954-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T11:27:08Z","timestamp":1764934028000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11954-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11954"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11954-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6453754\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"15 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study protocol was reviewed and approved by the\n                      Comit\u00e9 \u00c9thique et Scientifique pour les Recherches\n                      ,\n                      les \u00c9tudes et les \u00c9valuations dans le domaine de la Sant\u00e9\n                      (CESREES) on 8 October 2020 (No. TPS2483887) and by the\n                      Commission Nationale de l\u2019Informatique et des Libert\u00e9s\n                      (CNIL) on 1 February 2021 (CNIL, MLD\/VCS\/AR212214, No. 920458). Informed consent was waived by the\n                      Commission Nationale de l\u2019Informatique et des Libert\u00e9s\n                      (CNIL in French) as this study was retrospective on a pseudo-anonymised database and did not influence care. This study was conducted according to national laws, regulations, and the declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"BH and XD declare that they have no competing interests except consulting fees for this study.CC is employed by IQVIA which received funding from Sanofi to run the study.TN, AB and LF are Sanofi employees and may hold shares in the company.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1537"}}